Canton Strategic Holdings, Inc.

CNTN Healthcare Biotechnology

In the quarter to June 2026, EPS grew 85.9% and free cash flow fell 600.4%, each against the same quarter a year earlier.

1.70 0.17 −9.09%
Market cap
$149.0M
P/E
9.0×
Fwd P/E
—
Dividend yield
—
F-score
n/a
Altman Z
n/a
Beneish M
n/a
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
ROE

+8 more TTM periods

(225.01%) (17.99%) (34.42%) (43.10%)
ROA
(159.36%) (13.74%) (27.53%) (34.60%)
ROIC
0.00% (3.26%) (7.94%) (8.11%)
Return on Tangible Assets
(167.66%) (254.73%) (192.44%) (254.25%)
Free Cash Flow per Share
(1.40) (0.50) (0.10) (0.10)
Free Cash Flow
(8.72) (16.13) (21.07) (22.17)
Other line items

Show all line items

Columns are period end dates